Emerging market (EM) equities are starting 2026 with renewed momentum, supported by a combination of macroeconomic tailwinds, some evidence of structural profitability improvements, and strengthening investor sentiment.
At the start of 2025, EM investors faced a wide range of challenges, including:
However, these hurdles were overshadowed by three more powerful shifts:
Overall, EM equities had a fantastic 2025, posting a gain of +33.6—the best year versus developed markets since 2017 (the S&P 500 was up 17% and the MSCI World was +21%). Last year’s performance marked one of the best EM rallies since 2017. This year has started off strong, with the asset class rising 5%.1
After EM currencies appreciated strongly against the dollar in 2025, weakening in the dollar could help boost EM economies in the coming year. In addition, still-light positioning in EM equities globally, and the potential catch-up of EM profits to DM profits, adds to the performance momentum.
Some market participants have posited that the US administration may pivot from its unpredictable approach to US foreign policy, and instead focus on domestic issues in the run-up to the midterm elections. The first part of January suggests that this may have been a false hope. At the start of 2026, we think reallocations away from the US remain likely—especially as the US dollar remains quite expensive (in real terms) versus history. Since the end of the gold standard, the US dollar has only been this strong a few times.2 Thus far, investors have mostly been picking up dollar hedges, versus selling dollar assets specifically (Figure 1). However, there is risk here, and it will favor non-US assets for some time.
An enduring (and negative) theme that has kept investors on the sidelines in EM stocks is that they have been under-earning their US counterparts for some time. The inertia of the EM underweight has proven to be a solid trade through last year, but investors we speak to still view EM equities as a trading dynamic. On the flip side, we are starting to see some profit convergence (particularly in the major tech-related names) that is getting investors’ attention. This is occurring as valuations remain high for US assets and Europe remains in the crosshairs of geopolitical pressure.
If I had to give investors one trend to keep an eye on in 2026, it would be this emerging and developed market ROE convergence story.
Consensus is expecting 21% EPS growth in EM equities this year, which is substantially ahead of both the US and developed market (DM) (+15% and +13%, respectively).3 The more that EM can out-earn World ex US, and inch closer to World (Figure 2), the long-term investment case will build itself and EM equities could enter a new cycle of sustained strength.
Despite momentum throughout last year, most clients did not participate in the 2025 rally. According to State Street Investment Management data, aggregate positioning shows that global investors are still underweight EM. They are less underweight to be sure (there were especially large moves in Chinese exposure), but nonetheless, the conclusion is clear. Investors, broadly speaking, did not benefit from EM’s strong performance last year.
Moving forward, there is still potential for new money to enter the asset class. Digging deeper, EM Equity funds saw strong inflows (roughly $30 billion in 2025—the strongest since the post-COVID recovery). However, under the surface, the divergence was clear. The optimism was most prominent with ETF buyers, as EM ETFs saw inflows of nearly $88 billion. Meanwhile, non-ETFs saw outflows of $58 billion.4
As always, there are some uncertainties for investors to consider with respect to 2026 outcomes.
For more on potential surprises across the globe, read about our top Grey Swans.
Valuations remains one of the strongest arguments in favor of EM equities. Despite the rally in 2025, EM equities still trade at a significant discount to DM equities. This valuation gap has narrowed somewhat, but remains wide enough to attract global investors seeking diversification and growth at reasonable prices. However, need to consider:
We continue to favor Chinese stocks, largely funded by underweights in India. We continue to think India is one of the best investment stories over the medium term (five years), but the ingredients are just not aligned for this year. China has better value, momentum, and larger underweights to attract capital (and a more resilient FX). We are neutral to slightly underweight EMEA; the smaller markets may be tricky in 2026 after some big gains. Low oil prices may create some good entry points in the Middle Eastern markets, but we aren’t ready to buy.
Within the tech space, we also favor Korea and Taiwan. IT, financials, and communication services are the preferred sectors (funded by underweights in healthcare, utilities, and energy). We also prefer large caps over small caps this year.